“Europe at serious risk from a global pandemic? says Mario Pinca, Copma

FOR IMMEDIATE USE  18th December 2015: “Europe is at risk from a global pandemic if we fail to take immediate action. It has come to this. Anti-microbial resistance is out of control; but we can reduce the risk of antimicrobial resistance by improving the microbial ecosystem; with the probiotic bacteria-based PCHS system it is possible to get great results,” said Mario Pinca, CEO of Copma, a leading Italian services firm.

“By 2050, antimicrobial resistance could mean the loss of up to 444 million people of productive age – that’s $124.5 trillion,” according to RAND Europe, a not-for-profit research institute based in Cambridge (UK) and Brussels. If we don’t act now, Europe risks its health, wealth, and long-term economic advantage.”

“In mid-November, The Times of London wrote a leading editorial on a global pandemic threat. The Times said: “Drug resistant bacteria have breached our last line of defence”, and its leading columnist David Aaronovitch stated that we either: “Become anti-microbially aware or die.” It has come to this, and we must act,” said Pinca.

“Last month, European Commissioner for Health, Dr Vytenis Andriukaitis, and Louise Slaughter, the only microbiologist in the United States Congress, met in Washington to discuss antimicrobial resistance #AMR It is a sign of how traditional anti-microbial practices are failing. Patients are at risk. Livestock and livelihoods are in peril. But there is a solution.”

“Superbugs resisting even super-antibiotics, have led global health experts to speak openly of a post-antibiotic era. In recent weeks, addressing the United Kingdom’s parliament, Prime Minister David Cameron said that public health issues are part of a pattern of risks making the 21st Century a uniquely unstable moment. Cameron said new global health strategies are needed.”

“At Copma, we agree with Prime Minister Cameron, a new approach is needed; and with superbugs at least, there is an answer. Studies conducted by researchers at the University of Ferrara suggest we combat superbugs. The probiotics-based system ‘PCHS’ makes a safer health environment possible by deploying the low and stable presence of potentially pathogenic germs. It’s scientifically proven to be effective.”

“The most recent research was carried out by Professor Sante Mazzacane, Director of Research Center CIAS at the University of Ferrara. Mazzacane’s new study on the impact of the PCHS sanitation system, has focused on the microbiota of hospital surfaces. The study confirms results which are already the subject of previous international scientific publications relating to safety and hygiene; but it also highlights new potential scenarios concerning the reduction of resistance possessed by pathogens.”

“At Copma, we are advising Europe’s governments and health leaders to act without delay to secure our public health environment. Using the PCHS probiotic system, we have proven, and verified with independent research, that bacterial risk in hospitals can be significantly reduced. Professor Mazzacane’s research can help Europe reduce superbug risks in our health system, and globally. It is a new, strong weapon in the fight against a global pandemic. It has come to this. It is time to act,” said Alberto Rodolfi, President of Copma.

Professor Mazzacane’s findings are being published in international scientific journals.

Mario Pinca and Alberto Rodolfi are available for interview.

WATCH: Our Short Information Video Explaining Probiotics: https://youtu.be/N-ql4kR9ABs   

Captions:

  1. Mario Pinca, CEO of Copma
  2. Alberto Rodolfi, President of Copma
  3. Professor Sante Mazzacane, Director of the University Research Center CIAS

For More Information

Contact:

Copma Press Team

Email: press@copma.it

Tel: +39 (0)5 3297 0611 

www.copma.it

NOTES FOR EDITORS

COPMA SCRL, Italy

Copma SCRL, in collaboration with the most important Italian Universities, has developed, in recent years, a cleaning and hygiene system, the PCHS, a tried and tested hygiene protocol which, with the use of probiotics, can significantly reduce the risk of the transmission of healthcare associated infections; reducing direct and indirect costs.

Copma is a cooperative Company based in Ferrara, Italy, operating since 1971. Copma is structured to provide high quality services with particular reference to healthcare and hospitals throughout the Country.

WATCH: Our Short Information Video: https://youtu.be/N-ql4kR9ABs

THE COMPANY

The total number of employees - partners + non-members - at the end of 2014 was over 1,550.

We maintain a strong presence of women within our workforce - more than 94%

ENDS

Copma Press Team

Email: press@copma.it

Tel: 39 (0) 5 3297 0611 

www.copma.it 

COPMA SCRL,

Via Veneziani, 32-44124,

Ferrara, Italy 

Tags:

Media

Media

Quick facts

HAIs infect 4.1 million patients annually; and every year, 37,000 people in the EU die as a result of an HAI, even though 20%-30% of these infections are considered to be preventable by intensive hygiene and control programmes.
Tweet this

Quotes

“The University of Ferrara, as part of the scientific research carried out on the PCHS, has developed a new method of measuring the level of hospital hygiene. It is called I.Q.M. - ‘Indicators of Microbiological Quality’. These indicators can become a European reference for all operators in the sector, both for who provides the service and for the institutional levels, which govern them. They can measure safety, and help improve safety outcomes.
University of Ferrara